Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000118

EVP Chief Patient & Ext Af Off sold 1,846 shares at $486.35 ($897,802)

  • EVP Chief Patient & Ext Af Off gave up 1,518 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Sachdev Amit · EVP Chief Patient & Ext Af Off

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-24 Shares withheld for taxes : show line 1 in the form 10b5-1 −1,518 $485.11 $736,397 57,416 D
2026-02-25 Sale : show line 2 in the form 10b5-1 −1,846 $486.35 $897,802 55,570 D
Open-market sales · 1,846 sh · avg $486.35 · $897,802
Loading xslF345X05/wk-form4_1772149844.xml…